Switching to Glycerol Phenylbutyrate in 48 Patients with Urea Cycle Disorders: Clinical Experience in Spain

Background and objectives: Glycerol phenylbutyrate (GPB) has demonstrated safety and efficacy in patients with urea cycle disorders (UCDs) by means of its clinical trial program, but there are limited data in clinical practice. In order to analyze the efficacy and safety of GPB in clinical practice,...

Descripción completa

Detalles Bibliográficos
Autores principales: Martín-Hernández, Elena, Quijada-Fraile, Pilar, Correcher, Patricia, Meavilla, Silvia, Sánchez-Pintos, Paula, de las Heras Montero, Javier, Blasco-Alonso, Javier, Dougherty, Lucy, Marquez, Ana, Peña-Quintana, Luis, Cañedo, Elvira, García-Jimenez, María Concepción, Moreno Lozano, Pedro Juan, Murray Hurtado, Mercedes, Camprodon Gómez, María, Barrio-Carreras, Delia, de los Santos, Mariela, del Toro, Mireia, Couce, María L., Vitoria Miñana, Isidro, Morales Conejo, Montserrat, Bellusci, Marcello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457033/
https://www.ncbi.nlm.nih.gov/pubmed/36078975
http://dx.doi.org/10.3390/jcm11175045

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457033/
https://www.ncbi.nlm.nih.gov/pubmed/36078975
http://dx.doi.org/10.3390/jcm11175045

Ejemplares similares